Skip to main content

Illumina to Place BeadLab System at CHOP; Deal Could Exceed $25M

NEW YORK, June 7 (GenomeWeb News) - Illumina will provide The Children's Hospital of Philadelphia with its BeadLab genotyping system, the company said today.


The hospital will house the system at its new Center for Applied Genomics and will provide a core capability for CHOP's research goal of ultimately genotyping over 100,000 children with a focus on asthma, obesity, diabetes, and cancer, Illumina said.


According to the company, the initial value of the agreement, which includes arrays and reagents for the first 30,000 samples, is expected to exceed $25 million.


CHOP said that it plans to first conduct whole-genome genotyping using Sentrix HumanHap550 BeadChips, though subsequent phases of its research will use Illumina arrays and reagents to study focused sets of SNPs thought to be implicated in disease cause and progression.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.